PuSH - Publikationsserver des Helmholtz Zentrums München

Meredith, L.W.* ; Hu, K.* ; Cheng, X. ; Howard, C.R.* ; Baumert, T.F.* ; Balfe, P.* ; van de Graaf, K.F.* ; Protzer, U. ; McKeating, J.A.

Lentiviral hepatitis B pseudotype entry requires NTCP and additional hepatocyte-specific factors.

J. Gen. Virol. 97, 121-127 (2016)
Verlagsversion DOI PMC
Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
Hepatitis B virus (HBV) is one of the world's major unconquered infections, resulting in progressive liver disease and current treatments rarely cure infection. A major limitation to discovering new therapies is our limited knowledge of HBV entry and dissemination pathways that hinders the development of in vitro culture systems. To address this gap in our understanding we optimised the genesis of infectious lentiviral pseudoparticles (HBVpp). The recent discovery that the bile salt transporter NTCP acts as a receptor for HBV enabled us to assess the receptor dependency of HBVpp infection. HBVpp preferentially infect hepatoma cells expressing NTCP, whereas other non-liver cells engineered to express NTCP do not support infection, suggesting that additional hepatocyte-specific factors are required for HBVpp internalisation. These results highlight the value of the HBVpp system to dissect the pathways of HBV entry and dissemination.
Altmetric
Weitere Metriken?
[➜Einloggen]
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Korrespondenzautor
Schlagwörter Virus; Glycoproteins; Resistant; Mutants; Assay
ISSN (print) / ISBN 0022-1317
e-ISSN 1465-2099
Zeitschrift Journal of General Virology
Quellenangaben Band: 97, Heft: , Seiten: 121-127 Artikelnummer: , Supplement: ,
Verlag Society for General Microbiology
Verlagsort Reading
Nichtpatentliteratur Publikationen
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Virology (VIRO)